ecancer
@ecancer
Followers
17K
Following
6K
Media
5K
Statuses
22K
ecancer is a charity with a mission to raise the standards of care for cancer patients across the world through education. #openaccess
England
Joined February 2009
RT @nataliagandur: 💫🌟🚀 Top advances of the year: Bladder cancer🌟💫.@theNCI @TischCancer @theNCI @IMResidencyDuke @uamshealth .@apolo_andrea,….
0
18
0
📢 Excited for the 3rd @BalcoMedical Chhattisgarh Cancer Conclave + 6th ecancer #ChoosingWisely India, 2nd @csoncol India, & 2nd #NursingConclave!. 📅 19–21 Sep 2025 | 📍 Naya Raipur, Chhattisgarh. Focus: GI, GU & lung cancers with experts sharing insights to improve care.
0
1
2
RT @VHIO: #ESMOGI25 | Dr. Elena Élez shares insights with @ecancer on the #CheckMate8HW trial 🔬. 🎯 This study compares nivolumab + ipilimum….
ecancer.org
Dr Elena Elez speaks to ecancer about the health-related quality of life analyses from CheckMate 8HW. This clinical trial explores nivolumab plus ipilimumab
0
2
0
RT @businessnowke: More research is urgently needed on how to make palliative and supportive cancer care better and accessible to more peop….
businessnow.co.ke
Why research in palliative, supportive care should urgently be expanded Business Now Business Now Business Now Cancer -
0
1
0
RT @oncology_bg: Don’t miss out on this wonderful opportunity. It’s a high-impact fellowship that’ll allow you to learn health service and….
acsjournals.onlinelibrary.wiley.com
Although no survival benefit over standard therapies has been established, the combination of sotorasib plus panitumumab recently received full US Food and Drug Administration approval for use in...
0
6
0
RT @SIOGorg: Just 3 months left until the global #SIOGcommunity gathers in Ghent!.Join us for #SIOG2025, the leading event in #GeriatricOnc….
0
6
0
RT @nataliagandur: 🌟🚨 Landmark! #IMvigor011 🔬🌟. The first Phase III trial in muscle-invasive #BladderCancer using ctDNA MRD (Signatera™) to….
0
16
0
RT @jtgeorgy: 📢Our new paper @OffCMCVellore Pathology, MedOnc out in @ecancer After Dr. @ullas_batra's report, this….
0
10
0
📊 New bibliometric study in #ecancer: . “The state of global palliative care research” maps global productivity, reveals stark disparities & urges LMIC-focused research.🌍. High-income countries dominate output. ➡️ Discover the trends & gaps: #Palliative.
ecancer.org
The state of global palliative care research: a bibliometric study Mevhibe B Hocaoglu1,a, Grant Lewison2,b, Hamish Sharp2, Tania Pastrana3,c, Eve Namisango
0
0
0
RT @nataliagandur: 🌟🧬 Bladder Cancer & the Microbiome: A New Frontier. ✍️ Zhiwen Luo, @CoderDoge1108, Hantao Wang, Jianing Fu, Yiqiang Zhan….
0
11
0
🚀 New review in #ecancer: . “Changing Paradigms in Pediatric Cancer Care – Perspectives for India & LMICs” highlights precision medicine, immunotherapy & genetic predisposition. 🔍 Bridges global advances with local realities. Read more: #Pediatric.
ecancer.org
Changing paradigms in pediatric cancer care – the contemporary landscape and perspectives for India Badira Cheriyalinkal Parambil1, Nirmalya Roy Moulik1, V
0
0
0
RT @LuisRaezMD: Understanding genetic aberrations in lung cancer treatment: NTRK, RET, NRG - ecancer @NTRKers #lun….
ecancer.org
Dr Luis Raez reviews three key genetic fusions in non-small cell lung cancer (NSCLC): NTRK, RET, and NRG1. He begins with NTRK fusions, rare but highly actio
0
4
0
RT @BalcoMedical: 📅 19th–21st September 2025 . Stay tuned for agenda highlights and speaker announcements. @AnilAgarwalFndn @VedantaAlumi….
0
2
0
RT @LuisRaezMD: Understanding genetic aberrations in lung cancer treatment: NTRK, RET, NRG - ecancer
ecancer.org
Dr Luis Raez reviews three key genetic fusions in non-small cell lung cancer (NSCLC): NTRK, RET, and NRG1. He begins with NTRK fusions, rare but highly actio
0
1
0
ecancer joined Best of ASCO® 2025 with.@mhshospital.interviewing experts about the key highlights presented at ASCO 2025. 🔗 Watch all interviews here @LuisRaezMD. #BestOfASCO #ASCO2025 #Oncology #MedicalEducation #CancerCare #mhshospital
1
1
2
RT @nataliagandur: 🌟🔝 LATAM 💰💡 What if we could save $244 million/year while improving cancer care access in LATAM?.🔹 Economic Benefits of….
0
11
0
🌍 On #WorldHeadandNeckCancerDay . We highlight the urgent need for prevention, early detection, and access to treatment—especially in low-resource settings. Together we can reduce global disparities. #CancerEquity #HPV #TobaccoFree #ecancer #EducationSavesLives.
0
0
1
RT @TheLancet: The global burden of liver cancer is increasing. 📈 . Hepatocellular carcinoma (HCC) accounts for approximately 80% of cases….
0
92
0
📚Clinical study:. How effective is radical radiation for early-stage oropharyngeal cancer? ☢️. This single-institution study shares outcomes, insights & impact on patient care 🔎📈🔬. 📖Read more here #HeadAndNeckCancer #ecancer.
ecancer.org
Latest oncology resources showing current best practice in cancer research and treatment
0
0
0
RT @SamuelFodop: 🚨 PUBLICATION ALERT!. Only 13% of lung cancer patients in Africa survive 5 years post-treatment. 📉 81.5% are diagnosed at….
0
1
0